Assessing outcomes in Alzheimer disease.

Abstract Text

To gain a better overview of the effectiveness of treatment of patients with Alzheimer disease (AD), areas such as cognition, activities of daily living (ADL), behavior, caregiver burden, quality of life and economics need to be assessed. A number of instruments are available for assessing these domains, many of which are reviewed in this article. These include the cognitive subscale of the Alzheimer's Disease Assessment Scale (the standard instrument for the measurement of efficacy in dementia trials), scales that assess AD patients' abilities to perform ADL (including the Disability Assessment for Dementia scale and the Alzheimer's Disease Cooperative Study-Activities of Daily Living), scales to assess behavioral symptoms in dementia (including the Neuropsychiatric Inventory and the Behavioral Pathology in Alzheimer's Disease Rating Scale), scales for assessing global clinical change, and methods for assessing caregiver time, quality of life and health economics. Each instrument has its own advantages and disadvantages. However, the instruments used need to be selected carefully to provide credible and informative outcome data.

Authors :-,


Keywords :-, ,


Mesh Headings :-


Chemical List :-, ,



2016-09-03 12:38:19

Click download button below to get the free Assessing outcomes in Alzheimer disease. link to pdf of abstract on your facebook profile.

Download Server - Asia Download Server - America Download Server - Europe Download Server - Australia
Citation:- Schneider LS, .Assessing outcomes in Alzheimer disease. Alzheimer disease and associated disorders 2001-Aug;15 ()S8-18 DOI:



Details of Journal

Journal Title - Alzheimer disease and associated disorders

ISSN - 0893-0341

Volume - 15

Issue - 0

Publish date - 2001-Aug

Language - eng

Country - United States


SHARE PLEASE -
Read More Similar Articles

Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease.

Albuquerque EX, Santos EX, Alkondon EX, Pereira EX, Maelicke EX, .Modulation of nicotinic receptor activity in the central nervous system: a novel approach to the treatment of Alzheimer disease. Alzhe.......

Read More

DeKosky ST, Orgogozo ST, .Alzheimer disease: diagnosis, costs, and dimensions of treatment. Alzheimer disease and associated disorders 2001-Aug;15 ()S3-7 DOI:.......


Long-lasting rat growth enhancement by an immunoregulating synthetic peptide.

Carelli C, Guillon C, Gobert C, .Long-lasting rat growth enhancement by an immunoregulating synthetic peptide. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2001-Sep;55()404-12 DO.......

Read More

Comparison of calcitonin, alendronate and fluorophosphate effects on ovariectomized rat bone.

Giavaresi G, Fini G, Gnudi G, Aldini G, Rocca G, Carpi G, .Comparison of calcitonin, alendronate and fluorophosphate effects on ovariectomized rat bone. Biomedicine & pharmacotherapy = Biomédecine &.......

Read More

Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients.

Kovacs E, .Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérap.......

Read More

Prevention of pathologies associated with oxidative stress and dietary intake deficiencies: folate deficiency and requirements.

Tapiero H, Tew H, Gaté H, Machover H, .Prevention of pathologies associated with oxidative stress and dietary intake deficiencies: folate deficiency and requirements. Biomedicine & pharmacotherapy = .......

Read More

Immunodominant CD8 T cell response to Epstein-Barr virus.

Houssaint E, Saulquin E, Scotet E, Bonneville E, .Immunodominant CD8 T cell response to Epstein-Barr virus. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2001-Sep;55()373-80 DOI:.......

Read More

Genetics of Epstein-Barr virus infection.

Hiraki A, Fujii A, Masuda A, Ikeda A, Tanimoto A, .Genetics of Epstein-Barr virus infection. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2001-Sep;55()369-72 DOI:.......

Read More

Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients.

Sivaraman P, Lye P, .Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2001-Sep;55()366-8 DOI:.......

Read More